Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization.

MLA

Tarallo, Valeria, et al. “Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization.” International Journal of Molecular Sciences, vol. 21, no. 2, Jan. 2020. EBSCOhost, https://doi.org/10.3390/ijms21020410.

APA

Tarallo, V., Iaccarino, E., Cicatiello, V., Sanna, R., Ruvo, M., & De Falco, S. (2020). Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization. International Journal of Molecular Sciences, 21(2). https://doi.org/10.3390/ijms21020410

Chicago

Tarallo, Valeria, Emanuela Iaccarino, Valeria Cicatiello, Riccardo Sanna, Menotti Ruvo, and Sandro De Falco. 2020. “Oral Delivery of a Tetrameric Tripeptide Inhibitor of VEGFR1 Suppresses Pathological Choroid Neovascularization.” International Journal of Molecular Sciences 21 (2). doi:10.3390/ijms21020410.